The Austrian petrochemicals group OMV has filed a lawsuit against a total of four companies, including Clariant.
OMV is claiming damages totalling around €1 billion in a court in Amsterdam in connection with breaches of competition in the purchase of ethylene, Clariant announced on Tuesday.
At the same time, Clariant strictly rejects the allegations and intends to vigorously defend its rights in this matter. Clariant wants to have proof that the behaviour of the companies involved had no impact on the market.
Only around a fortnight ago, the chemical company Dow filed a claim for damages against Clariant and three other companies at a court in Munich, claiming damages of €767 million. This related to the infringements of competition law in the ethylene purchasing market sanctioned by the European Commission in July 2020.
Clariant already fined
Clariant, Orbia, Celanese and Westlake had colluded in the purchase of ethylene in order to achieve the lowest possible price. All four companies admitted their role in the cartel in summer 2020 and agreed to a settlement. Clariant paid a fine of €155.8 million.
A fortnight ago, however, Clariant also rejected Dow’s accusations. BASF filed a claim for damages in the same case in mid-January, TotalEnergies in February. The Germans are claiming damages of €1.4 billion from the four companies, while the French are claiming €625 million. Shell also filed a lawsuit in 2023.
Translated from French by DeepL/mga
How we work
We select the most relevant news for an international audience and use automatic translation tools such as DeepL to translate them into English. A journalist then reviews the translation for clarity and accuracy before publication. Providing you with automatically translated news gives us the time to write more in-depth articles. The news stories we select have been written and carefully fact-checked by an external editorial team from news agencies such as Bloomberg or Keystone.
Did you find this explanation helpful? Please fill out the short survey below to help us understand your needs.
Living longer: What do you think about the longevity trend?
The longevity market is booming thanks in part to advances in the science of ageing. What do you think of the idea of significantly extending human lifespan?
Swiss researchers develop new treatment against lymphoma
This content was published on
The cancer can be effectively combated with the radioactive element terbium. However, the therapy has not yet been tested on humans.
This content was published on
Florian Willet was present when the Sarco suicide capsule was first used in Switzerland in September 2024 and had been placed in pre-trial detention.
This content was published on
At the start of the 113th International Labour Conference in Geneva, Houngbo called for a "more efficient" organisation in front of the 187 member states
Microsoft invests $400 million in Swiss AI expansion
This content was published on
Among other things, the existing data centres in the Geneva and Zurich regions are being expanded as part of this investment.
This content was published on
This is the first study first to report a direct interaction between floating plastic debris in the atmosphere and any species.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.